Dr. Paige earned a Ph.D. in Immunology at the Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences in 1979.  He became a Member of the Basel Institute for Immunology in Switzerland where he worked from 1980-1987 before joining the Ontario Cancer Institute as a Senior Scientist in 1987.  In 1990, Dr. Paige became the founding Director of the Arthritis and Autoimmunity Research Centre as well as Director of Research at The Wellesley Hospital.  In 1998, he returned to the Ontario Cancer Institute to assume the role of Vice President, Research and, subsequently assumed his current position of Vice President, Research at the University Health Network, which comprises four hospitals: Toronto Rehab, Toronto General Hospital, Toronto Western Hospital and Princess Margaret Cancer Centre.  

Dr. Paige is a Professor in the Departments of Medical Biophysics and Immunology at the University of Toronto. He is an active educator in the undergraduate, graduate and postgraduate programs of the University’s School of Medicine.  He is an internationally recognized leader in the area of lymphocyte development and antibody formation, with an active research program in training the immune system to recognize cancer cells.  

He has served on the Research Advisory Boards of the National Cancer Institute and the Arthritis Society of Canada.  He is the past Chairman of the Board of the Biotechnology Commercialization Centre which helped establish a Toronto Biotechnology Incubator and past Chairman of BioDiscovery Toronto, a consortium of 12 Toronto-based hospitals and universities engaged in the commercialization of research discoveries.  He also serves on the Boards of the Terry Fox Research Institute, The Princess Margaret Cancer Foundation, Toronto General & Western Hospital Foundation, Arthritis Research Foundation, Council of Ontario Research Directors, and the Ontario Health Research Alliance.  Dr. Paige is also a co-founder and Chairman of the Board of GEMMA Biotechnology.  Its purpose is to discover and commercially develop biological response modifiers which influence the course of human disease. He was the Founder and co-Director of the Shanghai-Toronto Institute for Health Science (STI), a partnership between the Shanghai Institute of Health Sciences, Shanghai Institute of Organic Chemistry and the University Health Network. UHN currently maintains laboratories in the Zhangjiang High Technology Park in Pudong.

Read more about Dr. Paige's research interests.